Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-23 · accession 0001298711-22-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-28 | 2022-11-23 | KRYS | Krishnan Suma | Pres, R, D, Dir, 10% | S - Sale | $80.01 | -4 | 1.79M | -0.0% | -$320.04 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-23 | S | D | 4 | $80.01 | 1,787,718 | I By Spouse | — | — | (F2) These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. (F3) Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. |